Next Quarterly Earnings
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Theravance Biopharma is a US-based biopharmaceutical company specializing in the development of innovative medicines. The company focuses on researching targeted therapies for the treatment of serious respiratory and inflammatory diseases through the use of advanced pharmaceutical compounds.
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Theravance Biopharma is scheduled to report its next quarterly earnings on 11/10/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Theravance Biopharma last reported quarterly earnings on 8/10/2026 (Q2 2026). Earnings per share (EPS) came in at -0.11 USD.
Theravance Biopharma has beaten analyst EPS estimates in 3 of its last 5 evaluated quarters (beat rate: 60%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.